Aurinia Pharmaceuticals AUPH Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's operating lease right-of-use assets in other assets?
- Aurinia Pharmaceuticals (AUPH) reported operating lease right-of-use assets in other assets of $1.66M in Q1 2026.
- How has Aurinia Pharmaceuticals's operating lease right-of-use assets in other assets changed year-over-year?
- Aurinia Pharmaceuticals's operating lease right-of-use assets in other assets decreased by 58.0% year-over-year, from $3.95M to $1.66M.
- What is the long-term trend for Aurinia Pharmaceuticals's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's operating lease right-of-use assets in other assets has grown at a -8.1% compound annual growth rate (CAGR), from $5.49M to $3.6M.